Allele Capital Partners

Allele Capital Partners is a merchant bank based in Lauderdale, Florida, established in 2017. The firm specializes in providing venture capital and private equity financing to private and small-cap public companies within the healthcare and life sciences sectors. Allele partners with clients to deliver a range of services, including strategic advisory, capital raising, and transaction execution. Their offerings encompass various financing options such as mezzanine financing, alternative public offerings, initial public offerings, private placements, and secondary offerings. Additionally, Allele provides advisory services that include capital markets access, fairness opinions, and corporate services, facilitating comprehensive support for their clients' financial needs.

Ankit Bhargava

Managing Director

Brian Debeer

COO

Matt Hughes

Managing Partner

George Kogan

Managing Director

Menachem Kranz

Co-Founder and Partner

Tom Masterson

Managing Director

Shawn Titcomb

Co-Founder and CEO

Harshawardhan Bal Ph.D

Managing Director

1 past transactions

Coya Therapeutics

Series A in 2021
Coya Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies that enhance the function of regulatory T cells (Tregs) in vivo. The company is advancing multiple first-in-class and best-in-class approaches, including allogeneic Treg-derived exosome therapeutics and novel biologics. Coya's proprietary medicinal products are designed to modulate Treg function, targeting a range of conditions such as neurodegenerative, autoimmune, and metabolic diseases. By harnessing the therapeutic potential of Tregs, Coya Therapeutics aims to address significant unmet medical needs in these critical areas of health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.